← Eichor
Condition: Chronic Inducible Urticaria Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Inducible Urticaria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associat
Phase 1 · 1 location(s) · Akros Pharma Inc. · NCT07247266A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · 73 location(s) · Celldex Therapeutics · NCT07266402Deep Phenotyping of CIndU
Phase N/A · 3 location(s) · Centre for Human Drug Research, Netherlands · NCT07359430Analysis of the Role of IgE Proteoforms in Health and Disease
Phase N/A · 1 location(s) · KU Leuven · NCT07328178Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chron
Phase 2 · 17 location(s) · Novartis Pharmaceuticals · NCT06865651Ilaris NIS in Korea
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT06838143Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06974877Circadian Rhythm Deregulation in Patients With CAPS
NA · 6 location(s) · Hospices Civils de Lyon · NCT06544018Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stil
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02974595A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of
Phase 1 · 1 location(s) · Enanta Pharmaceuticals, Inc · NCT07540910A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
Phase 1 · 2 location(s) · Granular Therapeutics Limited · NCT07181369
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.